Gilead Sciences | 税前利润



Pre Tax Profit 更改 日
AbbVie USD 4.81B 1.54B 2024-12
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
ALKERMES USD 443.75M 333.52M 2024-12
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Glaxosmithkline USD 1.66B 1.78B 2024-12
Incyte USD 234.19M 172.64M 2025-03
J&J USD 13.63B 8.21B 2025-03
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sanofi EUR 2.16B 20M 2025-03
Sarepta Therapeutics USD -383518000 555.26M 2025-03
United Therapeutics USD 423.5M 27M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Gilead Sciences 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.